Transplant hepatology fellow at the University of Michigan and co-lead of the Liver Fellow Network

Alan L. Hutchison is an MD- and PhD- trained transplant hepatologist-scientist and Clinical Instructor of Medicine at the University of Chicago. He obtained his B.S. in Physics from Yale University, followed by an M.D. and Ph.D. in Computational Biology and Biophysics from the University of Chicago. His PhD thesis focused on developing statistical methods for understanding circadian rhythm data.

Chemical Biology PhD Candidate at the University of Michigan, working under Dr. Jonathan Sexton. Focused on using patient-derived liver organoids to model clinically significant hepatotoxicity.

Dr. Juliane I. Beier is an Assistant Professor at the University of Pittsburgh School of Medicine in the Department of Medicine with a secondary appointment in the Graduate School of Public Health. She is a member of both the Pittsburgh Liver Research Center and the UPMC Hillman Cancer Center.

Dr. Frederick Adams Ekuban is an Assistant Professor of Medicine in the Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition at the University of Louisville School of Medicine. His research program in environmental health and toxicology focuses on elucidating the molecular mechanisms by which environmental pollutants, particularly per- and polyfluoroalkyl substances (PFAS), interact with lifestyle factors to promote liver disease.

Maria Mironova, MD, MHSc is a research gastroenterology fellow at the University of California, San Diego, specializing in metabolic dysfunction–associated steatotic liver disease. She previously completed a hepatology fellowship at the National Institutes of Health, focusing on non-cirrhotic portal hypertension and omics-based approaches to understanding liver injury in MASLD.

Dr. Bogdanov was born and raised in San Francisco, CA before moving to Los Angeles for his education and training. He obtained his BS in Biochemistry from UCLA, and his MD from the Keck School of Medicine of USC where he remains for his internal medicine residency. Dr. Bogdanov has over twelve years of basic and translational research experience with expertise in tissue injury and regeneration, cellular and molecular signaling, and small molecule drug discovery. Dr. Bogdanov is currently a post-doctoral researcher in the laboratory of Dr.

Kerry Sivia is a patient advocate living with metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune hepatitis, primary biliary cholangitis (PBC), and cirrhosis. Since receiving her diagnoses in 2021, she has become a leading voice for patient-centered advocacy in hepatology care, focusing on multidisciplinary collaboration, health equity, and the lived experience of people affected by liver disease.

Susan Horava, a certified health coach, serves as the Director of Ambassador and Lifestyle Management Programs at Liver Education Advocates. After years of battling undiagnosed elevated liver enzymes and debilitating fatigue, an ultrasound revealed her fatty liver disease. This progressed to a diagnosis of metabolic-related cirrhosis. Fueled by resolve, Susan immersed herself in researching metabolic liver disease, embracing the transformative power of whole foods, regular exercise, and quality sleep. She was able to achieve fibrosis regression and a stabilized low MELD score.

Dr. Jonathan Stine is an Associate Professor of Medicine and Public Health Science at Penn State where he serves as the Fatty Liver Program Director and Liver Center Research Director. As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD), he has authored more than 125 peer-reviewed papers, including multinational consensus guidelines for the American College of Sports Medicine and Exercise and Sports Science Australia, and has lectured across the United States and Europe. Dr.